Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A multi-ingredient phytotherapeutic combination consisting of extracts from saw palmetto, tomato (lycopene), uva ursi, pygeum, and pumpkin. This specific formulation is being investigated by Ain Shams University for the treatment of Chronic Prostatitis Category IIIB (Chronic Pelvic Pain Syndrome), often in combination with Extracorporeal Shock-Wave Therapy (ESWT). The components work synergistically through several mechanisms: saw palmetto and pygeum inhibit 5-alpha-reductase and provide anti-inflammatory effects by inhibiting cyclooxygenase and lipoxygenase pathways; tomato provides lycopene, a potent antioxidant; uva ursi acts as a urinary antiseptic; and pumpkin seed extract supports prostate health through phytosterols. In Egypt, this combination is commercially available as Prostacure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saw palmetto + tomato + uva ursi + pygeum + pumpkin.